Salina Husain

Salina Husain

Auto-generated profile, based on publicly available information

Salina Husain

Department of Otorhinolaryngology-Head and Neck Surgery, Universiti Kebangsaan Malaysia Medical Centre, Kuala Lumpur, Malaysia

Research Focus & Metrics

Academic Career Length

66Years (1961-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Rhinology journal
Verified
Journal Article
Closed access
WFW.J. Fokkens
W.J. Fokkens
VLV.J. Lund
V.J. Lund
CHC. Hopkins
C. Hopkins
PHP.W. Hellings
P.W. Hellings
RKR. Kern
R. Kern
CZC.P. Zwetsloot
C.P. Zwetsloot
The European Position Paper on Rhinosinusitis and Nasal Polyps 2020 is the update of similar evidence based position papers published in 2005 and 2007 and 2012. The core objective of the EPOS2020 guideline is to provide revised, up-to-date and clear evidence-based recommendations and integrated care pathways in ARS and CRS. EPOS2020 provides an update on the literature published and studies undertaken in the eight years since the EPOS2012 position paper was published and addresses areas not extensively covered in EPOS2012 such as paediatric CRS and sinus surgery. EPOS2020 also involves new stakeholders, including pharmacists and patients, and addresses new target users who have become more involved in the management and treatment of rhinosinusitis since the publication of the last EPOS document, including pharmacists, nurses, specialised care givers and indeed patients themselves, who employ increasing self-management of their condition using over the counter treatments. The document provides suggestions for future research in this area and offers updated guidance for definitions and outcome measurements in research in different settings. EPOS2020 contains chapters on definitions and classification where we have defined a large number of terms and indicated preferred terms. A new classification of CRS into primary and secondary CRS and further division into localized and diffuse disease, based on anatomic distribution is proposed. There are extensive chapters on epidemiology and predisposing factors, inflammatory mechanisms, (differential) diagnosis of facial pain, allergic rhinitis, genetics, cystic fibrosis, aspirin exacerbated respiratory disease, immunodeficiencies, allergic fungal rhinosinusitis and the relationship between upper and lower airways. The chapters on paediatric acute and chronic rhinosinusitis are totally rewritten. All available evidence for the management of acute rhinosinusitis and chronic rhinosinusitis with or without nasal polyps in adults and children is systematically reviewed and integrated care pathways based on the evidence are proposed. Despite considerable increases in the amount of quality publications in recent years, a large number of practical clinical questions remain. It was agreed that the best way to address these was to conduct a Delphi exercise . The results have been integrated into the respective sections. Last but not least, advice for patients and pharmacists and a new list of research needs are included. The full document can be downloaded for free on the website of this journal: http://www.rhinologyjournal.com.

2 August 2022 in Journal of Asthma and Allergy
Verified
Journal Article
Open access
PDF file
Baharudin AbdullahBaharudin Abdullah
Baharudin Abdullah
ALAmir Hamzah Abdul Latiff
Amir Hamzah Abdul Latiff
AMAnura Michelle Manuel
Anura Michelle Manuel
FJFaizah Mohamed Jamli
Faizah Mohamed Jamli
HSHarvinder Singh Dalip Singh
Harvinder Singh Dalip Singh
Ralph MösgesRalph Mösges
Ralph Mösges
The goal of allergic rhinitis (AR) management is to achieve satisfactory symptom control to ensure good quality of life. Most patients with AR are currently treated with pharmacotherapy. However, knowledge gaps on the use of pharmacotherapy still exist among physicians, particularly in the primary care setting, despite the availability of guideline recommendations. Furthermore, it is common for physicians in the secondary care setting to express uncertainty regarding the use of new combination therapies like intranasal corticosteroid plus antihistamine combinations. Inadequate treatment leads to significant reduction of quality of life that affects daily activities at home, work, and school. With these concerns in mind, a practical consensus statement was developed to complement existing guidelines on the rational use of pharmacotherapy in both the primary and secondary care settings.

1 May 2020 in European Annals of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
NNN. Norhafizah
N. Norhafizah
HSH. Salina
H. Salina
BGB.S. Goh
B.S. Goh
N. Saifudina nschemistry@yahoo.com 1 S. Husaina 1 B.S. Goha 2 N. Saifudina nschemistry@yahoo.com 1 S. Husaina 1 B.S. Goha 2 1 Department of...

12 December 2018 in Surgical and Radiologic Anatomy
Verified
Journal Article
Closed access
PDF file
Baharudin AbdullahBaharudin Abdullah
Baharudin Abdullah
ELEng Haw Lim
Eng Haw Lim
SHSalina Husain
Salina Husain
KSKornkiat Snidvongs
Kornkiat Snidvongs
DWDe Yun Wang
De Yun Wang

12 March 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Baharudin AbdullahBaharudin Abdullah
Baharudin Abdullah
SCShiun Chuen Chew
Shiun Chuen Chew
MAMohd Ezane Aziz
Mohd Ezane Aziz
NSNorasnieda Md Shukri
Norasnieda Md Shukri
SHSalina Husain
Salina Husain
KSKornkiat Snidvongs
Kornkiat Snidvongs
Keros and Gera classifications are widely used to assess the risk of skull base injury during endoscopic sinus surgery. Although, both classifications are useful preoperatively to stratify risk of patients going for surgery, it is not practical to measure the respective lengths during surgery. In this study, we aimed to propose a new radiological classification (Thailand-Malaysia-Singapore (TMS)) to assess the anatomical risk of anterior skull base injury using the orbital floor (OF) as a reference. A total of 150 computed tomography images of paranasal sinuses (300 sides) were reviewed. The TMS classification was categorized into 3 types by measuring OF to cribriform plate and OF to ethmoid roof. Most patients were classified as TMS type 1, Keros type 2 and Gera class II, followed by patients classified as TMS type 3, Keros type 1 and Gera class 1. TMS has significant correlation with Keros classification (p < 0.05). There was no significant correlation between Keros and Gera classifications (p = 0.33) and between TMS and Gera classifications (p = 0.80). The TMS classification has potential to be used for risk assessment of skull base injury among patients undergoing ESS. It serves as an additional assessment besides the Keros and Gera classifications.

10 November 2018 in Journal of Biomaterials Science, Polymer Edition
Verified
Journal Article
Closed access
SGSarumathi Gobinathan
Sarumathi Gobinathan
SZSiti Solehah Zainol
Siti Solehah Zainol
SASiti Fatmah Azizi
Siti Fatmah Azizi
NINabil Mohamad Iman
Nabil Mohamad Iman
RMRajasegaran Muniandy
Rajasegaran Muniandy
YLYogeswaran Lokanathan
Yogeswaran Lokanathan
Amniotic membrane has the potential to be used as scaffold in various tissue engineering applications. However, increasing its biostability at the same time maintaining its biocompatibility is important to enhance its usage as a scaffold. This studied characteristics genipin-crosslinked amniotic membrane as a bioscaffold. Redundant human amniotic membranes (HAM) divided into native (nAM), decellularized (dAM) and genipin-crosslinked (clAM) groups. The dAM and clAM group were decellularized using thermolysin (TL) and sodium hydroxide (NaOH) solution. Next, clAM group was crosslinked with 0.5% and 1.0% (w/v) genipin. The HAM was then studied for in vitro degradation, percentage of swelling, optical clarity, ultrastructure and mechanical strength. Meanwhile, fibroblasts isolated from nasal turbinates were then seeded onto nAM, dAM and clAM for biocompatibility studies. clAM had the slowest degradation rate and were still morphologically intact after 30 days of incubation in 0.01% collagenase type 1 solution. The dAM had a significantly highest percentage of swelling than other groups (p < 0.05). Besides, the dAM retained the collagen content at similar level of nAM. Although the dAM had highest mechanical strength compared to the rest of the groups, the differences were statistically insignificant. Cell attachment on dAM and 0.5% clAM was higher compared to that on nAM and 1.0% clAM. In conclusion, clAM have better biostability and biocompatibility compared to the nAM and dAM. Together with other suitable characteristics of the clAM such as percentage of swelling, structural integrity and ECM content, clAM is suitable as scaffold for various tissue engineering applications.